0001938571 2025-01-01 2025-12-31 0001938571 2026-06-11 0001938571 2025-06-30 shares iso4217:USD true FY 0001938571 10-K/A true 2025-12-31 --12-31 2025 false 000-56583 ADAPTIN BIO, INC. DE 88-1566415 3540 Toringdon Way Suite 200 #250 Charlotte NC 28277 (888) 609-1498 N/A true No No Yes Yes Non-accelerated Filer true true false false false false 9300000 8903229 Not applicable On April 1, 2026, Adaptin Bio, Inc. (the “Company”) filed with the Securities and Exchange Commission (“SEC”) its Annual Report on Form 10-K for the year ended December 31, 2025 (the “Original Form 10-K”).This Amendment No. 1 to Form 10-K (the “Form 10-K/A”) of the Company is being filed solely to amend Item 15(b) and Exhibit 23.1 to include an updated consent of WithumSmith+Brown, PC, the Company’s independent registered public accounting firm, to include references to a registration statement of the Company which was inadvertently omitted from the original consent filed.This Form 10-K/A should be read in conjunction with the Original Form 10-K and includes only the portions of the Original Form 10-K being supplemented or amended by this Form 10-K/A. Other than as described in this explanatory note, this Form 10-K/A does not change any of the financial or other information set forth in the Original Form 10-K or the exhibits thereto. This Form 10-K/A does not reflect events that may have occurred subsequent to the filing of the Original Form 10-K.